Comparative efficacy of different durations and dosages of vonoprazan and amoxicillin dual therapy: a network meta-analysis of randomized controlled trials
Abstract
Background: The combination of vonoprazan and amoxicillin (VA) has been shown to be effective in eradicating Helicobacter pylori infection; however, the optimal treatment duration and dosage are yet to be determined.
Methods: A systematic literature search of PubMed, Embase, and China National Knowledge Infrastructure was performed to identify randomized controlled trials (RCTs) comparing different durations of VA dual therapy or comparing this dual therapy with bismuth-containing quadruple therapy (BQT). All trials were conducted in China. A Bayesian network meta-analysis was used to evaluate the eradication rates and incidence of adverse events across different treatment regimens.
Results: Thirty-eight randomized controlled trials were ultimately included in the analysis. Network meta-analysis revealed that both the 14- and 10-day VA regimens achieved higher eradication rates compared with BQT, with odds ratios (OR) of 1.7 [95% credible interval (CrI) 1.3-2.1] and 1.4 (95% CrI 1.1-2.0), respectively. The 7-day regimen did not yield a difference in eradication rate compared with BQT (P > 0.05). All VA dual therapy regimens were associated with lower rates of adverse events than those for BQT. Among patients receiving the 14-day VA dual therapy regimen, there was no difference in eradication rates between the high- and low-dose groups. The low-dose 14-day regimen was associated with higher eradication outcomes than the low-dose 10-day regimen. No significant differences in…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
- Treatment and prognostic factors for long-term outcome in patients with anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis: a cohort study
- Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study
- Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study
- Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank
- Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.